Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ling Zhang, Kathy L. McGraw, David A. Sallman & Alan F. List. (2017) The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications. Leukemia & Lymphoma 58:8, pages 1777-1790.
Read now
Read now
Articles from other publishers (71)
Mochen Guo, Zekun Li, Mingxiao Gu, Junrui Gu, Qidong You & Lei Wang. (2023) Targeting phosphatases: From molecule design to clinical trials. European Journal of Medicinal Chemistry, pages 116031.
Crossref
Crossref
Elham F. Ahanin, Rebecca A. Sager, Sarah J. Backe, Diana M. Dunn, Natela Dushukyan, Adam R. Blanden, Nilamber A. Mate, Tamie Suzuki, Tyler Anderson, Merin Roy, Jasmeen Oberoi, Chrisostomos Prodromou, Imad Nsouli, Michael Daneshvar, Gennady Bratslavsky, Mark R. Woodford, Dimitra Bourboulia, John D. Chisholm & Mehdi Mollapour. (2023) Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer. Cell Chemical Biology 30:10, pages 1223-1234.e12.
Crossref
Crossref
Ye Feng, Erminia Massarelli, Eric Forman, John S Kovach, Ravi Salgia & Timothy W Synold. (2023) An LC–MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasma. Bioanalysis 15:17, pages 1095-1107.
Crossref
Crossref
Zhaoshi Bai, Yiran Zhou, Yaling Peng, Xinyue Ye & Lingman Ma. (2023) Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:5, pages 188965.
Crossref
Crossref
Isha Mondal, Oishika Das, Raymond Sun, Jian Gao, Bohyeon Yu, Aaron Diaz, Jinan Behnan, Abhishek Dubey, Zhipeng Meng, Emad Eskandar, Beisi Xu, Rongze Olivia Lu & Winson S. Ho. (2023) PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma. Cancer Research 83:15, pages 2527-2542.
Crossref
Crossref
Virginie Emond-Fraser, Myreille Larouche, Peter Kubiniok, Éric Bonneil, Jingjing Li, Mohammed Bourouh, Laura Frizzi, Pierre Thibault & Vincent Archambault. (2023)
Identification of PP2A-B55 targets uncovers regulation of emerin during nuclear envelope reassembly in
Drosophila
. Open Biology 13:7.
Crossref
Crossref
Natalia García-Flores, Jaime Jiménez-Suárez, Cristina Garnés-García, Diego M. Fernández-Aroca, Sebastia Sabater, Ignacio Andrés, Antonio Fernández-Aramburo, María José Ruiz-Hidalgo, Borja Belandia, Ricardo Sanchez-Prieto & Francisco J. Cimas. (2023) P38 MAPK and Radiotherapy: Foes or Friends?. Cancers 15:3, pages 861.
Crossref
Crossref
Ning Zhang, Cailing Lu, Jiao Mo, Xinhang Wang, Simi Liao, Ningjing Liang, Mei Feng, Tingting Tang, Yijie Wu, Yunqing Li, Chunhua Lan, Chengying Chen, Qianqian Shi, Lancheng Wei, Zhijian Zheng, Yu Lei, Zhiming Zhang, Shen Tang & Xiyi Li. (2023) LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma. Translational Oncology 27, pages 101572.
Crossref
Crossref
Johanna L. Mehl, Ashley Earle, Jan Lammerding, Musa Mhlanga, Viola Vogel & Nikhil Jain. (2022) Blockage of lamin-A/C loss diminishes the pro-inflammatory macrophage response. iScience 25:12, pages 105528.
Crossref
Crossref
Elham Kashani & Erik Vassella. (2022) Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype. Cancers 14:21, pages 5227.
Crossref
Crossref
Xiaochao Tang, Dianmei Yu, Haiyan Wang, Zhixiang Lei, Yiwen Zhai, Minglu Sun, Si Chen, Ying Wang, Zhen Liu, Weijun Hu & Xianchun Wang. (2022) Synaptotagmin 1-mediated cell membrane penetration and dopamine release enhancement by latroeggtoxin-VI. International Journal of Biological Macromolecules 216, pages 906-915.
Crossref
Crossref
Amandeep Thakur, Chetna Faujdar, Ram Sharma, Sachin Sharma, Basant Malik, Kunal Nepali & Jing Ping Liou. (2022) Glioblastoma: Current Status, Emerging Targets, and Recent Advances. Journal of Medicinal Chemistry 65:13, pages 8596-8685.
Crossref
Crossref
Buket Ozel, Sezgi Kipcak, Cigir Biray Avci, Cumhur Gunduz, Guray Saydam, Cagdas Aktan & Nur Selvi Gunel. (2022) Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells. Medical Oncology 39:4.
Crossref
Crossref
Nicola M. Sergienko, Daniel G. Donner, Lea M.D. Delbridge, Julie R. McMullen & Kate L. Weeks. (2022) Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. Cellular Signalling 91, pages 110213.
Crossref
Crossref
Margaret Hayne & Aaron DiAntonio. (2022) Protein phosphatase 2A restrains DLK signaling to promote proper Drosophila synaptic development and mammalian cortical neuron survival. Neurobiology of Disease 163, pages 105586.
Crossref
Crossref
Samantha L Tinsley & Brittany L Allen-Petersen. (2022) PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen. NAR Cancer 4:1.
Crossref
Crossref
Yu-Ting Yen, May Chien, Pei-Yi Wu, Chi-Chang Ho, Chun-Te Ho, Kevin Chih-Yang Huang, Shu-Fen Chiang, K. S. Clifford Chao, William Tzu-Liang Chen & Shih-Chieh Hung. (2021) Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response. Nature Communications 12:1.
Crossref
Crossref
Mohammad Houshmand, Alireza Kazemi, Ali Anjam Najmedini, Muhammad Shahzad Ali, Valentina Gaidano, Alessandro Cignetti, Carmen Fava, Daniela Cilloni, Giuseppe Saglio & Paola Circosta. (2021) Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells. Journal of Clinical Medicine 10:24, pages 5805.
Crossref
Crossref
Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, Mohd W. Nasser, Emily Miaou, Sharad S. Singhal, Saumya Srivastava, Isa Mambetsariev, Michael S. Nelson, Arin Nam, Amita Behal, Pranita Atri, Markus Muschen, François L.H. Tissot, James Miser, John S. Kovach, Martin Sattler, Surinder K. Batra, Prakash Kulkarni & Ravi Salgia. (2021) Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Molecular Cancer Therapeutics 20:10, pages 1820-1835.
Crossref
Crossref
Qi Song, Herui Wang, Dongxian Jiang, Chen Xu, Jing Cui, Qi Zhang, Haixing Wang, Jie Huang, Jieakesu Su, Gen Sheng Wu, Zhengping Zhuang & Yingyong Hou. (2021) Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC). Cancers 13:19, pages 4766.
Crossref
Crossref
Bo Sun, Fang-Jing Zhong, Cong Xu, Yi-Ming Li, Yan-Rong Zhao, Mo-Mo Cao & Lian-Yue Yang. (2021) Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation. Cell Death & Disease 12:9.
Crossref
Crossref
Julie J Miller. (2021) Targeting protein arginine methylation to death. Neuro-Oncology 23:9, pages 1421-1422.
Crossref
Crossref
Yoshihiro Otani, Hannah P Sur, Guruprasad Rachaiah, Sriya Namagiri, Ashis Chowdhury, Cole T Lewis, Toshihiko Shimizu, Arunakumar Gangaplara, Xiang Wang, Amélie Vézina, Dragan Maric, Sadhana Jackson, Yuanqing Yan, Zhuang Zhengping, Abhik Ray-Chaudhury, Sachin Kumar, Leomar Y Ballester, Prashant Chittiboina, Ji Young Yoo, John Heiss, Balveen Kaur & Yeshavanth Kumar Banasavadi-Siddegowda. (2021) Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma. Neuro-Oncology 23:9, pages 1481-1493.
Crossref
Crossref
Qiuyue Zhang, Zhongjiao Fan, Lianshan Zhang, Qidong You & Lei Wang. (2021) Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer. Journal of Medicinal Chemistry 64:13, pages 8916-8938.
Crossref
Crossref
Yue Zheng, Heidi L. Schubert, Parmit K. Singh, Laura J. Martins, Alan N. Engelman, Iván D’Orso, Christopher P. Hill & Vicente Planelles. (2021) Cleavage and Polyadenylation Specificity Factor 6 Is Required for Efficient HIV-1 Latency Reversal. mBio 12:3.
Crossref
Crossref
Jean-Paul Bryant, Adam Levy, John Heiss & Yeshavanth Kumar Banasavadi-Siddegowda. (2021) Review of PP2A Tumor Biology and Antitumor Effects of PP2A Inhibitor LB100 in the Nervous System. Cancers 13:12, pages 3087.
Crossref
Crossref
Xiao Jiang, Jiandong Hu, Ziru Wu, Sarah Trusso Cafarello, Mario Di Matteo, Ying Shen, Xue Dong, Heike Adler, Massimiliano Mazzone, Carmen Ruiz de Almodovar & Xiaohong Wang. (2021) Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Julia P. Vainonen, Majid Momeny & Jukka Westermarck. (2021) Druggable cancer phosphatases. Science Translational Medicine 13:588.
Crossref
Crossref
Anne Slomp, Laura M. Moesbergen, Eric Eldering, Marie José Kersten, Monique C. Minnema & Victor Peperzak. (2021) Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells. Cell Death & Disease 12:3.
Crossref
Crossref
Zachary R. Woydziak, A. John Yucel & A. Richard Chamberlin. (2020) Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I. ChemMedChem 16:5, pages 839-850.
Crossref
Crossref
Benjamin Bonavida. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer
225
242
.
David Olayinka Kamson, Harmon Singh Khela & John Laterra. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
31
77
.
Xiao Lei, Na Ma, Lehui Du, Yanjie Liang, Pei Zhang, Yanan Han & Baolin Qu. (2020) PP2A and tumor radiotherapy. Hereditas 157:1.
Crossref
Crossref
Chun Shik Park & H. Daniel Lacorazza. (2020) DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells. Experimental & Molecular Medicine 52:10, pages 1663-1672.
Crossref
Crossref
Lu Zhao, Ran Li, Jian-Zhong Qiu, Jiang-Bo Yu, Yang Cao & Rong-Tao Yuan. (2020) YY1-mediated PTEN dephosphorylation antagonizes IR-induced DNA repair contributing to tongue squamous cell carcinoma radiosensitization. Molecular and Cellular Probes 53, pages 101577.
Crossref
Crossref
Manuel Ehling, Ward Celus, Rosa Martín-Pérez, Roser Alba-RoviraSander Willox, Donatella PontiMaria C. CidElizabeth A.V. Jones, Giusy Di Conza & Massimiliano Mazzone. (2020) B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling. Circulation Research 127:6, pages 707-723.
Crossref
Crossref
Shanmuga Subbiah, Arin Nam, Natasha Garg, Amita Behal, Prakash Kulkarni & Ravi Salgia. (2020) Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research. Journal of Clinical Medicine 9:8, pages 2433.
Crossref
Crossref
Dominic Maggio, Winson S. Ho, Rebecca Breese, Stuart Walbridge, Herui Wang, Jing Cui, John D. Heiss, Mark R. Gilbert, John S. Kovach, Rongze O. Lu & Zhengping Zhuang. (2020) Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma. Journal of Neuro-Oncology 148:2, pages 231-244.
Crossref
Crossref
Lalita Oparija-Rogenmozere, Anuradha Rajendran, Nadège Poncet, Simone M. R. Camargo & François Verrey. (2020) Phosphorylation of mouse intestinal basolateral amino acid uniporter LAT4 is controlled by food-entrained diurnal rhythm and dietary proteins. PLOS ONE 15:5, pages e0233863.
Crossref
Crossref
Jing Cui, Herui Wang, Rogelio Medina, Qi Zhang, Chen Xu, Iris H. Indig, Jingcheng Zhou, Qi Song, Pauline Dmitriev, Mitchell Y. Sun, Liemei Guo, Yang Wang, Jared S. Rosenblum, John S. Kovach, Mark R. Gilbert & Zhengping Zhuang. (2020) Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma. Cancers 12:1, pages 139.
Crossref
Crossref
Zachary J. Brandt, Ashley E. Echert, Jonathan R. Bostrom, Paula N. North & Brian A. Link. (2020) Core Hippo pathway components act as a brake on Yap/Taz in the development and maintenance of the biliary network. Development.
Crossref
Crossref
Hermann AM Mucke. (2019) Patent highlights June–July 2019. Pharmaceutical Patent Analyst 8:6, pages 225-231.
Crossref
Crossref
Kathrin Schramm, Murat Iskar, Britta Statz, Natalie Jäger, Daniel Haag, Mikołaj Słabicki, Stefan M Pfister, Marc Zapatka, Jan Gronych, David T W Jones & Peter Lichter. (2019) DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas. Neuro-Oncology 21:7, pages 867-877.
Crossref
Crossref
Mohammad Houshmand, Giorgia Simonetti, Paola Circosta, Valentina Gaidano, Alessandro Cignetti, Giovanni Martinelli, Giuseppe Saglio & Robert Peter Gale. (2019) Chronic myeloid leukemia stem cells. Leukemia 33:7, pages 1543-1556.
Crossref
Crossref
Michiel Remmerie & Veerle Janssens. (2019) PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Pegah Javadpour, Leila Dargahi, Abolhassan Ahmadiani & Rasoul Ghasemi. (2019) To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling. Cellular and Molecular Life Sciences.
Crossref
Crossref
Brandon M. D'Arcy, Mark R. Swingle, Cinta M. Papke, Kevin A. Abney, Erin S. Bouska, Aishwarya Prakash & Richard E. Honkanen. (2019) The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C. Molecular Cancer Therapeutics 18:3, pages 556-566.
Crossref
Crossref
Gretchen M. Ehrenkaufer, Susmitha Suresh, David Solow-Cordero & Upinder Singh. (2018) High-Throughput Screening of Entamoeba Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
Goutham Narla, Jaya Sangodkar & Christopher B. Ryder. (2018) The impact of phosphatases on proliferative and survival signaling in cancer. Cellular and Molecular Life Sciences 75:15, pages 2695-2718.
Crossref
Crossref
Somy Yoon, Taewon Kook, Hyun-Ki Min, Duk-Hwa Kwon, Young Kuk Cho, Mira Kim, Sera Shin, Hosouk Joung, Seung Hoon Jeong, Sumin Lee, Gaeun Kang, Yunchul Park, Yong Sook Kim, Youngkeun Ahn, Julie R. McMullen, Ulrich Gergs, Joachim Neumann, Kyung Keun Kim, Jungchul Kim, Kwang-Il Nam, Young-Kook Kim, Hyun Kook & Gwang Hyeon Eom. (2018) PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart. Experimental & Molecular Medicine 50:7, pages 1-14.
Crossref
Crossref
Winson S. Ho, Herui Wang, Dominic Maggio, John S. Kovach, Qi Zhang, Qi Song, Francesco M. Marincola, John D. Heiss, Mark R. Gilbert, Rongze Lu & Zhengping Zhuang. (2018) Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade. Nature Communications 9:1.
Crossref
Crossref
Nobuhiko Itami, Koumei Shirasuna, Takehito Kuwayama & Hisataka Iwata. (2018) Palmitic acid induces ceramide accumulation, mitochondrial protein hyperacetylation, and mitochondrial dysfunction in porcine oocytes†. Biology of Reproduction 98:5, pages 644-653.
Crossref
Crossref
Maria Rita Fabbrizi, Barbara Meyer, Sandeep Misri, Suyash Raj, Cheri L. Zobel, Dennis E. Hallahan & Girdhar G. Sharma. (2018) Transient PP2A inhibition alleviates normal tissue stem cell susceptibility to cell death during radiotherapy. Cell Death & Disease 9:5.
Crossref
Crossref
Caitlin M. O’Connor, Abbey Perl, Daniel Leonard, Jaya Sangodkar & Goutham Narla. (2018) Therapeutic targeting of PP2A. The International Journal of Biochemistry & Cell Biology 96, pages 182-193.
Crossref
Crossref
Bob Meeusen & Veerle Janssens. (2018) Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification. The International Journal of Biochemistry & Cell Biology 96, pages 98-134.
Crossref
Crossref
Damian Lai, Min Chen, Jiechuang Su, Xiaohu LiuKatharina RotheKaiji HuDonna L. ForrestConnie J. Eaves, Gregg B. Morin & Xiaoyan Jiang. (2018)
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL
+
human leukemia
. Science Translational Medicine 10:427.
Crossref
Crossref
Markus Müschen. (2018) Autoimmunity checkpoints as therapeutic targets in B cell malignancies. Nature Reviews Cancer 18:2, pages 103-116.
Crossref
Crossref
Winson S. Ho, Saman Sizdahkhani, Shuyu Hao, Hua Song, Ashlee Seldomridge, Anita Tandle, Dragan Maric, Tamalee Kramp, Rongze Lu, John D. Heiss, Kevin Camphausen, Mark R. Gilbert, Zhengping Zhuang & Deric M. Park. (2018) LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Letters 415, pages 217-226.
Crossref
Crossref
Nando Cervone, Rosa Della Monica, Angela Flavia Serpico, Cinzia Vetrei, Mario Scaraglio, Roberta Visconti & Domenico Grieco. (2017) Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1. Oncotarget 9:7, pages 7312-7321.
Crossref
Crossref
Henan Zhao, Duojiao Li, Baojing Zhang, Yan Qi, Yunpeng Diao, Yuhong Zhen & Xiaohong Shu. (2017) PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer. Molecules 22:12, pages 2277.
Crossref
Crossref
Ji Young Lee, Mi-Sook Kim, Mi So Lee, Jae Eun Ju, Namhyun Chung & Youn Kyoung Jeong. (2017) Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A. Bioscience Reports 37:6.
Crossref
Crossref
Yu-Hang Zhang, Tao Huang, Lei Chen, YaoChen Xu, Yu Hu, Lan-Dian Hu, Yudong Cai & Xiangyin Kong. (2017) Identifying and analyzing different cancer subtypes using RNA-seq data of blood platelets. Oncotarget 8:50, pages 87494-87511.
Crossref
Crossref
Matthias Dedobbeleer, Estelle Willems, Stephen Freeman, Arnaud Lombard, Nicolas Goffart & Bernard Rogister. (2017) Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences. Biochemical Journal 474:17, pages 2903-2924.
Crossref
Crossref
Sai-Lan Liu, Huan-Xin Lin, Chu-Yong Lin, Xiao-Qing Sun, Li-Ping Ye, Fang Qiu, Wen Wen, Xin Hua, Xian-Qiu Wu, Jun Li, Li-Bing Song & Ling Guo. (2017) TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition. Cancer Letters 402, pages 117-130.
Crossref
Crossref
Vincent Chung, Aaron S. Mansfield, Fadi Braiteh, Donald Richards, Henry Durivage, Richard S. Ungerleider, Francis Johnson & John S. Kovach. (2017) Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial. Clinical Cancer Research 23:13, pages 3277-3284.
Crossref
Crossref
Mark Swingle, Claude-Henry Volmar, S. Adrian Saldanha, Peter Chase, Christina Eberhart, Edward A. Salter, Brandon D’Arcy, Chad E. Schroeder, Jennifer E. Golden, Andrzej Wierzbicki, Peter Hodder & Richard E. Honkanen. (2017) An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C). SLAS Discovery 22:1, pages 21-31.
Crossref
Crossref
Peter P. Ruvolo. (2016) The broken “Off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance. BBA Clinical 6, pages 87-99.
Crossref
Crossref
Yuwei Cong, Liangyan Wang, Zigui Wang, Shasha He, Dongfang Zhou, Xiabin Jing & Yubin Huang. (2016) Enhancing Therapeutic Efficacy of Cisplatin by Blocking DNA Damage Repair. ACS Medicinal Chemistry Letters 7:10, pages 924-928.
Crossref
Crossref
Godfrey Grech, Shawn Baldacchino, Christian Saliba, Maria Pia Grixti, Robert Gauci, Vanessa Petroni, Anthony G. Fenech & Christian Scerri. (2016) Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options. Tumor Biology 37:9, pages 11691-11700.
Crossref
Crossref
Stefano Ferrari & Christian Gentili. (2016) Maintaining Genome Stability in Defiance of Mitotic DNA Damage. Frontiers in Genetics 7.
Crossref
Crossref
Winson S. Ho, Michael J. Feldman, Dragan Maric, Lauren Amable, Matthew D. Hall, Gerald M. Feldman, Abhik Ray-Chaudhury, Martin J. Lizak, Juan-Carlos Vera, R. Aaron Robison, Zhengping Zhuang & John D. Heiss. (2016) PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells. Oncotarget 7:11, pages 12447-12463.
Crossref
Crossref